Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 26, 2019
Patent Application Number
15313145
Date Filed
May 22, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the angiotensinogen (AGT) gene, and methods of using such RNAi agents to inhibit expression of AGT and methods of treating subjects having an AGT-associated disorder, e.g., hypertension.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
